Skip to main navigation Skip to search Skip to main content

Efficacy and safety results of FGFR1-3 inhibitor, tinengotinib, as monotherapy in patients with advanced, metastatic cholangiocarcinoma: Results from phase II clinical trial

  • Milind M. Javle
  • , Amit Mahipal
  • , Lionel Aurelien Kankeu Fonkoua
  • , Christos Fountzilas
  • , Daneng Li
  • , Meredith Pelster
  • , Chih Yi Liao
  • , Donald A. Richards
  • , Dustin A. Deming
  • , Mohamad Ahmad Younes
  • , Parvez Mantry
  • , Allen Lee Cohn
  • , Ed Kingsley
  • , Jean Fan
  • , Peng Peng
  • , Caixia Sun
  • , Hui Wang
  • , Katie Hennessy
  • , Yujun Shan
  • , Frank Wu

Research output: Contribution to journal › Article › peer-review

15   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety results of FGFR1-3 inhibitor, tinengotinib, as monotherapy in patients with advanced, metastatic cholangiocarcinoma: Results from phase II clinical trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology